[Guidelines for diagnosis, treatment management pathways, and quality control of ovarian cancer in county-level regions (2025 edition)].

Q3 Medicine
{"title":"[Guidelines for diagnosis, treatment management pathways, and quality control of ovarian cancer in county-level regions (2025 edition)].","authors":"","doi":"10.3760/cma.j.cn112152-20241129-00543","DOIUrl":null,"url":null,"abstract":"<p><p>To establish diagnosis, treatment management pathways, and quality control guidelines tailored to county-level hospitals, standardize ovarian cancer care, improve treatment quality, and promote the equitable distribution of high-quality medical resources, the Expert Committee on Ovarian Cancer under the National Cancer Quality Control Center formulated the \"<i>Guidelines for diagnosis, treatment management pathways, and quality control of ovarian cancer in county-level regions (2025 edition)\"</i>. This guideline integrates existing national standards for ovarian cancer diagnosis and treatment with evidence-based medicine and clinical expertise. Structured as a pathway framework, this guideline addresses hierarchical diagnosis and treatment, diagnostic workflows, therapeutic approaches, and follow-up protocols for ovarian cancer in county-level settings, offering 13 specific recommendations. The guideline clarifies the roles of county-level hospitals in ovarian cancer management, including primary diagnosis and treatment, administration of antitumor therapies, maintenance therapy, adverse event management, recurrence monitoring, rehabilitation guidance, two-way referrals, and follow-up. For cases beyond local capacity, timely referral to higher-level hospitals or qualified county-level facilities is advised. County-level hospitals may perform surgery for early-stage ovarian cancer, but suspected advanced-stage cases should be promptly referred. The guideline emphasizes the importance of multidisciplinary collaboration in county-level hospitals and recommend that initial chemotherapy for newly diagnosed patients should be conducted at higher-level or adequately equipped county-level institutions. Follow-up evaluations may be performed locally, but suspected recurrence or metastasis requires referral to higher-level hospitals for assessment. Detailed pathways are provided for diagnosis, treatment (including surgery, chemotherapy, maintenance therapy, and recurrence management), and follow-up, with recommendations for incorporating online follow-up methods to enhance patient monitoring. By defining the roles of county-level hospitals, standardizing referral processes, and strengthening multidisciplinary coordination, the guideline aims to promote standardized ovarian cancer care. Its implementation is expected to improve county-level hospitals' diagnostic and therapeutic capabilities, foster collaboration with higher-level institutions, and ultimately enhance patient outcomes and quality of life. These efforts will optimize medical resource allocation, elevate national ovarian cancer care standards, and advance balanced regional healthcare development.</p>","PeriodicalId":39868,"journal":{"name":"中华肿瘤杂志","volume":"47 3","pages":"201-210"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华肿瘤杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112152-20241129-00543","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

To establish diagnosis, treatment management pathways, and quality control guidelines tailored to county-level hospitals, standardize ovarian cancer care, improve treatment quality, and promote the equitable distribution of high-quality medical resources, the Expert Committee on Ovarian Cancer under the National Cancer Quality Control Center formulated the "Guidelines for diagnosis, treatment management pathways, and quality control of ovarian cancer in county-level regions (2025 edition)". This guideline integrates existing national standards for ovarian cancer diagnosis and treatment with evidence-based medicine and clinical expertise. Structured as a pathway framework, this guideline addresses hierarchical diagnosis and treatment, diagnostic workflows, therapeutic approaches, and follow-up protocols for ovarian cancer in county-level settings, offering 13 specific recommendations. The guideline clarifies the roles of county-level hospitals in ovarian cancer management, including primary diagnosis and treatment, administration of antitumor therapies, maintenance therapy, adverse event management, recurrence monitoring, rehabilitation guidance, two-way referrals, and follow-up. For cases beyond local capacity, timely referral to higher-level hospitals or qualified county-level facilities is advised. County-level hospitals may perform surgery for early-stage ovarian cancer, but suspected advanced-stage cases should be promptly referred. The guideline emphasizes the importance of multidisciplinary collaboration in county-level hospitals and recommend that initial chemotherapy for newly diagnosed patients should be conducted at higher-level or adequately equipped county-level institutions. Follow-up evaluations may be performed locally, but suspected recurrence or metastasis requires referral to higher-level hospitals for assessment. Detailed pathways are provided for diagnosis, treatment (including surgery, chemotherapy, maintenance therapy, and recurrence management), and follow-up, with recommendations for incorporating online follow-up methods to enhance patient monitoring. By defining the roles of county-level hospitals, standardizing referral processes, and strengthening multidisciplinary coordination, the guideline aims to promote standardized ovarian cancer care. Its implementation is expected to improve county-level hospitals' diagnostic and therapeutic capabilities, foster collaboration with higher-level institutions, and ultimately enhance patient outcomes and quality of life. These efforts will optimize medical resource allocation, elevate national ovarian cancer care standards, and advance balanced regional healthcare development.

求助全文
约1分钟内获得全文 求助全文
来源期刊
中华肿瘤杂志
中华肿瘤杂志 Medicine-Medicine (all)
CiteScore
1.40
自引率
0.00%
发文量
10433
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信